Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics

By

  • John J Cush, Chief, Rheumatology and Clinical Immunology, Presbyterian Hospital of Dallas Clinical Professor of Internal Medicine,
  • Kathryn Dao

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today--drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.
View full description

 

Book information

  • Published: November 2012
  • Imprint: SAUNDERS
  • ISBN: 978-1-4557-5065-8